In addition to SMARCA2 and SMARCA4, our researchidentified several sgRNAs targeting other mSWI/SNF components which weresignificantly enriched in SCLC-P cells, including BRD9. This evidence concerns the gene SMARCA2 and small cell lung carcinoma.